- Home
- ESPR vs VHI Comparison
ESPR vs VHI Comparison
Compare ESPR & VHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- VHI
- Stock Information
- Founded
- ESPR 2008
- VHI 1932
- Country
- ESPR United States
- VHI United States
- Employees
- ESPR N/A
- VHI N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- VHI Major Chemicals
- Sector
- ESPR Health Care
- VHI Industrials
- Exchange
- ESPR Nasdaq
- VHI Nasdaq
- Market Cap
- ESPR 534.3M
- VHI 454.3M
- IPO Year
- ESPR 2013
- VHI N/A
- Fundamental
- Price
- ESPR $2.97
- VHI $13.87
- Analyst Decision
- ESPR Buy
- VHI Sell
- Analyst Count
- ESPR 6
- VHI 1
- Target Price
- ESPR $6.50
- VHI $12.00
- AVG Volume (30 Days)
- ESPR 7.1M
- VHI 12.7K
- Earning Date
- ESPR 11-06-2025
- VHI 11-06-2025
- Dividend Yield
- ESPR N/A
- VHI 2.27%
- EPS Growth
- ESPR N/A
- VHI 269.89
- EPS
- ESPR N/A
- VHI 3.44
- Revenue
- ESPR $268,125,000.00
- VHI $2,093,500,000.00
- Revenue This Year
- ESPR $18.83
- VHI $22.20
- Revenue Next Year
- ESPR N/A
- VHI $7.66
- P/E Ratio
- ESPR N/A
- VHI $4.03
- Revenue Growth
- ESPR N/A
- VHI 4.04
- 52 Week Low
- ESPR $0.69
- VHI $13.65
- 52 Week High
- ESPR $3.94
- VHI $41.75
- Technical
- Relative Strength Index (RSI)
- ESPR 59.21
- VHI 37.18
- Support Level
- ESPR $2.80
- VHI $14.35
- Resistance Level
- ESPR $3.11
- VHI $15.31
- Average True Range (ATR)
- ESPR 0.17
- VHI 0.52
- MACD
- ESPR 0.01
- VHI -0.01
- Stochastic Oscillator
- ESPR 76.47
- VHI 2.70
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About VHI Valhi Inc.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.